Cerebral Thrombolysis in Rural Residents Aged ≥ 80

References

• Information of the Minister of Health on the impact of demographic changes and an aging population on the organization of the health care system and the National Health Program (on 19.02.2016). Available from: https://stat.gov.pl/files/gfx/portalinformacyjny/pl/defaultaktualnosci/5468/24/1/1/ludnosc_w_wieku_60._struktura_demograficzna_i_zdrowie.pdf. Accessed 1130, 2019.
   Google Scholar
• Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global burden of diseases, injuries, and risk factors study 2010 (GBD 2010) and the GBD stroke experts group. Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet. 2014;383(9913):245–254. doi:10.1016/S0140-6736(13)61953-424449944
   PubMed Web of Science ®Google Scholar
• Błażejewska-Hyżorek B, Czernuszenko A, Członkowska A, et al. Postępowanie w udarze mózgu: wytyczne Grupy Ekspertów Sekcji Chorób Naczyniowych Polskiego Towarzystwa Neurologicznego. Neurol Neurochir Pol. 2012;46(1):3–78. doi:10.5114/ninp.2012.2717922426757
   PubMed Web of Science ®Google Scholar
• Scott PA, Meurer WJ, Frederiksen SM, et al. A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial. Lancet Neurol. 2013;12(2):139–148. doi:10.1016/S1474-4422(12)70311-323260188
   PubMed Web of Science ®Google Scholar
• Kunisawa S, Kobayashi D, Lee J, et al. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23(4):724–731. doi:10.1016/j.jstrokecerebrovasdis.2013.06.03323910512
   PubMed Web of Science ®Google Scholar
• Strbian D, Michel P, Ringleb P, et al. Relationship between onset-to-door time and door-to-thrombolysis time: a pooled analysis of 10 dedicated stroke centers. Stroke. 2013;44(10):2808–2813. doi:10.1161/STROKEAHA.113.00099523887834
   PubMed Web of Science ®Google Scholar
• Paul CL, Ryan A, Rose S, et al. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care. Implement Sci. 2016;11:51. doi:10.1186/s13012-016-0414-627059183
   PubMed Web of Science ®Google Scholar
• Boulanger JM, Lindsay MP, Gubitz G, et al. Canadian stroke best practice recommendations for acute stroke management: prehospital, emergency department, and acute inpatient stroke care, 6th edition, update 2018. Int J Stroke. 2018;13(9):949–984. doi:10.1177/174749301878661630021503
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the guidelines for early management of acute ischemic stroke: a guideline for health care professionals from American heart association/American stroke association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.000000000000021131662037
   PubMed Web of Science ®Google Scholar
• Błażejewska-Hyżorek B, Czernuszenko A, Członkowska A, et al. Wytyczne postępowania w udarze mózgu. Polski Przeglad Neurologiczny. 2019;15(suppl.A):30–92. doi:10.5603/PPN.2019.0001
   Google Scholar
• Stanny M. Demographic changes of the rural population and its labor resources. Polityka Spoleczna. 2012;460(7):1–9.
   Google Scholar
• Edwards LL. Using tPA for acute stroke in a rural setting. Neurology. 2007;68(4):292–294. doi:10.1212/01.wnl.0000253190.40728.0c17242335
   PubMed Web of Science ®Google Scholar
• Vaishnav AG, Pettigrew LC, Ryan S. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals. Clin Neurol Neurosurg. 2008;110(5):451–454. doi:10.1016/j.clineuro.2008.01.01018353532
   PubMed Web of Science ®Google Scholar
• Kozera G, Chwojnicki K, Gójska-Grymajlo A, Gasecki D, Schminke U, Nyka WM. Pre-hospital delays and intravenous thrombolysis in urban and rural areas. Acta Neurol Scand. 2012;126(3):171–177. doi:10.1111/j.1600-0404.2011.01616.x22077692
   PubMed Web of Science ®Google Scholar
• Sobolewski P, Szczuchniak W, Sobota A, Grzesik M. Are there differences between rural and urban populations in long-term outcome after systemic cerebral thrombolysis in a hospital located in an agricultural region? Rural Remote Health. 2014;14(4):2867.25494905
   PubMed Web of Science ®Google Scholar
• Członkowska A, Sarzynska-Długosz I, Niewada M, Kobayashi A. Eligibility of stroke units in Poland for administration of intravenous thrombolysis. Eur J Neurol. 2006;13(3):220–224. doi:10.1111/j.1468-1331.2006.01171.x16618336
   PubMed Web of Science ®Google Scholar
• Adams HP, Del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke. A guidelines for the early management of adults with ischemic stroke: a guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups. The American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(18):e478–e534. doi:10.1161/CIRCULATIONAHA.107.18148617515473
   PubMed Web of Science ®Google Scholar
• Ringleb PA, Bousser MG, Ford G, et al. European stroke organisation (ESO) executive committee; ESO writing committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457–507.18477843
   PubMed Web of Science ®Google Scholar
• Członkowska A, Kobayashi A. Management of acute stroke – guidelines from the expert group of the section of cerebrovascular diseases of the polish neurological society. Update 2013: thrombolysis. Neurol Neurochir Pol. 2013;47(4):303–309. doi:10.5114/ninp.2013.3675423986419
   PubMed Web of Science ®Google Scholar
• Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group. Stroke. 1994;25(11):2220–2226. doi:10.1161/01.STR.25.11.22207974549
   PubMed Web of Science ®Google Scholar
• Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19(12):1497–1500. doi:10.1161/01.STR.19.12.14973201508
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet. 1998;352(9136):1245–1251. doi:10.1016/S0140-6736(98)08020-99788453
   PubMed Web of Science ®Google Scholar
• for the ECASS Investigators; Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischaemic stroke. N Engl J Med. 2008;359(13):1317–1329. doi:10.1056/NEJMoa080465618815396
   PubMed Web of Science ®Google Scholar
• IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379(9834):2352–2363. doi:10.1016/S0140-6736(12)60768-522632908
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;2014(7):CD000213.
   PubMedGoogle Scholar
• Lorenzano S, Vestri A, Bovi P, et al. Thrombolysis in elderly stroke patients in Italy (TESPI) trial and updated meta-analysis of randomized controlled trials [published online ahead of print, 2019 Oct 26]. Int J Stroke. 2019;1747493019884525.31657284
   PubMed Web of Science ®Google Scholar
• Kapral MK, Austin PC, Jeyakumar G, et al. Rural-urban differences in stroke risk factors, incidence, and mortality in people with and without prior stroke the CANHEART stroke study. Circ Cardiovasc Qual Outcomes. 2019;12(2):e004973. doi:10.1161/CIRCOUTCOMES.118.00497330760007
   PubMed Web of Science ®Google Scholar
• Joubert J, Prentice LF, Moulin T, et al. Stroke in rural areas and small communities. Stroke. 2008;39(6):1920–1928. doi:10.1161/STROKEAHA.107.50164318420955
   PubMed Web of Science ®Google Scholar
• Lindroth M, Lundqvist R, Lilja M, Eliasson M. Cardiovascular risk factors differ between rural and urban Sweden: the 2009 Northern Sweden MONICA cohort. BMC Public Health. 2014;14:825. doi:10.1186/1471-2458-14-82525106746
   PubMed Web of Science ®Google Scholar
• Rural population 2014/2015 Department of environment food and rural affairs. Available from: https://www.gov.uk/government/publications/rural-population-and-migration/rural-population-201415. Accessed 820, 2020.
   Google Scholar
• Baernholdt M, Yan G, Hinton I, Rose K, Mattos M. Quality of life in rural and urban adults 65 years and older: findings from the National health and nutrition examination survey. J Rural Health. 2012;28(4):339–347. doi:10.1111/j.1748-0361.2011.00403.x23083080
   PubMed Web of Science ®Google Scholar
• Wach-Klink A, Paciura K, Zwadowska A, Adamczak M, Strojewska W, Frańczak-Prochowski T. The impact of selected cardiovascular factors on the safety and efficacy of intravenous thrombolysis for acute ischemic stroke in routine practice in a rural hospital. Med Stud. 2018;34(3):232–240. doi:10.5114/ms.2018.78687
   Web of Science ®Google Scholar
• Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011;97(10):787–796. doi:10.1136/hrt.2010.21853721478383
   PubMed Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968. doi:10.1001/jama.2013.18418224002282
   PubMed Web of Science ®Google Scholar
• Rural health information hub. Rural health disparities. Available from: https://www.ruralhealthinfo.org/topics/rural-health-disparities. Accessed 1130, 2019.
   Google Scholar
• Bolin JN, Bellamy GR, Ferdinand AO, et al. Rural healthy people 2020: new decade, same challenges. J Rural Health. 2015;31(3):326–333. doi:10.1111/jrh.1211625953431
   PubMed Web of Science ®Google Scholar
• Płaczkiewicz D, Puźniak M, Kleinrok A. Prevalence of hypertension and major cardiovascular risk factors in healthy residents of a rural region in south-eastern Poland – 1997–2008/9. Ann Agric Environ Med. 2016;23(3):476–481. doi:10.5604/12321966.121919127660872
   PubMed Web of Science ®Google Scholar
• Wang J, Ning X, Yang L, et al. Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991–2011. J Hum Hypertens. 2014;28(1):25–31. doi:10.1038/jhh.2013.4423739160
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Dorman PJ, Lewis SC, Sandercock PA. Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT? J Neurol Neurosurg Psychiatry. 1999;67(5):651–653. doi:10.1136/jnnp.67.5.65110519873
   PubMed Web of Science ®Google Scholar
• Menon BK, Puetz V, Kochar P, Demchuk AM. ASPECTS and other neuroimaging scores in the triage and prediction of outcome in acute stroke patients. Neuroimaging Clin N Am. 2011;21(2):407–423. doi:10.1016/j.nic.2011.01.00721640307
   PubMed Web of Science ®Google Scholar
• Zou M, Churilov L, He A, Campbell B, Davis SM, Yan B. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke. J Clin Neurosci. 2013;20(7):984–987. doi:10.1016/j.jocn.2012.10.01323664409
   PubMed Web of Science ®Google Scholar
• Tanaka K, Matsumoto S, Furuta K, et al. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis. J Thromb Thrombolysis. 2019:1–7. doi:10.1007/s11239-019-01979-7
   Web of Science ®Google Scholar
• Alhusban A, Fagan SC. Secondary prevention of stroke in the elderly: a review of the evidence. Am J Geriatr Pharmacother. 2011;9(3):143–152. doi:10.1016/j.amjopharm.2011.04.00221570361
   PubMedGoogle Scholar
• Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Arch Neurol. 2008;65(6):607–611. doi:10.1001/archneur.65.5.noc7007718332238
   PubMedGoogle Scholar
• Hacke W, Lichy C. Thrombolysis for acute stroke under antiplatelet therapy: safe enough to be beneficial? Nat Rev Neurol. 2008;4(9):474–475. doi:10.1038/ncpneuro0867
   Web of Science ®Google Scholar
• Diedler J, Ahmed N, Sykora M, et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke. 2010;41(2):288–294. doi:10.1161/STROKEAHA.109.55972420056933
   PubMed Web of Science ®Google Scholar
• Xian Y, O’Brien EC, Liang L, et al. Association of predicting Antithrombotic Treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA. 2017;317(10):1057–1067. doi:10.1001/jama.2017.137128291892
   PubMed Web of Science ®Google Scholar
• Martín-Pérez M, Gaist D, de Abajo FJ, García Rodríguez LA. Predictors of over-anticoagulation in warfarin users in the UK general population: a nested case-control study in a primary health care database. Thromb Haemost. 2019;119(1):66–76. doi:10.1055/s-0038-167651930597501
   PubMed Web of Science ®Google Scholar
• Le Reste JY, Chiron B, Le Floch B, et al. There are considerable drawbacks to oral anticoagulant for monitoring patients at home which should lead family physicians to discuss alternative or enhanced solutions: a cross-sectional study. BMC Cardiovasc Disord. 2013;13:71. doi:10.1186/1471-2261-13-7124024556
   PubMed Web of Science ®Google Scholar
• Dennis J, Majoni W, Tinsley J, Kangaharan N. Safety and efficacy of warfarin therapy in remote communities of the top end of Northern Australia. Heart Lung Circ. 2017;26(12):1291–1296. doi:10.1016/j.hlc.2017.01.00428262339
   PubMed Web of Science ®Google Scholar
• Wang S, Gross H, Lee SB, et al. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke. 2004;35(7):1763–1768. doi:10.1161/01.STR.0000131858.63829.6e15166386
   PubMed Web of Science ®Google Scholar
• Charipar R, Charipar E. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital. WMJ. 2008;107(4):176–180.18702433
   PubMedGoogle Scholar
• Muengtaweepongsa S, Prapa-Anantachai P, Dharmasaroja PA. Not only the Sugar, Early infarct sign, hyperDense middle cerebral artery, Age, Neurologic deficit score but also atrial fibrillation is predictive for symptomatic intracranial hemorrhage after intravenous recombinant tissue plasminogen activator. J Neurosci Rural Pract. 2017;8(1):49–54. doi:10.4103/0976-3147.19354828149081
   PubMed Web of Science ®Google Scholar
• Di Carlo A, Lamassa M, Baldereschi M, et al. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. J Neurol Sci. 2006;244(1–2):143–150. doi:10.1016/j.jns.2006.01.01616530226
   PubMed Web of Science ®Google Scholar
• Sandercock P, Bamford J, Dennis M, et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). BMJ. 1992;305:1460–1465. doi:10.1136/bmj.305.6867.14601493391
   PubMed Web of Science ®Google Scholar
• Touzé E, Gruel Y, Gouin-Thibault I, et al. Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants. Eur J Neurol. 2018;25(5):747–e52. doi:10.1111/ene.1358229360254
   PubMed Web of Science ®Google Scholar
• Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. American heart association stroke council and council on epidemiology and prevention. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(2):581–641. doi:10.1161/STR.000000000000008626696642
   PubMed Web of Science ®Google Scholar
• Emberson J, Lees KR, Lyden P, et al. Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929–1935. doi:10.1016/S0140-6736(14)60584-525106063
   PubMed Web of Science ®Google Scholar
• Qu X, Shi J, Cao Y, Zhang M, Xu J. Prognostic value of white blood cells counts and c reactive protein an acut ischemic stroke patients after intravenous thrombolysis. Curr Neurovasc Res. 2018;15(1):10–17. doi:10.2174/156720261566618032610152429577860
   PubMed Web of Science ®Google Scholar